BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 24743742)

  • 1. Opposing TNF-α/IL-1β- and BMP-2-activated MAPK signaling pathways converge on Runx2 to regulate BMP-2-induced osteoblastic differentiation.
    Huang RL; Yuan Y; Tu J; Zou GM; Li Q
    Cell Death Dis; 2014 Apr; 5(4):e1187. PubMed ID: 24743742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
    Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
    J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation.
    Guicheux J; Lemonnier J; Ghayor C; Suzuki A; Palmer G; Caverzasio J
    J Bone Miner Res; 2003 Nov; 18(11):2060-8. PubMed ID: 14606520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Jun N-terminal kinase 1 negatively regulates osteoblastic differentiation induced by BMP2 via phosphorylation of Runx2 at Ser104.
    Huang YF; Lin JJ; Lin CH; Su Y; Hung SC
    J Bone Miner Res; 2012 May; 27(5):1093-105. PubMed ID: 22247071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diosmetin induces human osteoblastic differentiation through the protein kinase C/p38 and extracellular signal-regulated kinase 1/2 pathway.
    Hsu YL; Kuo PL
    J Bone Miner Res; 2008 Jun; 23(6):949-60. PubMed ID: 18269307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanical stress-mediated Runx2 activation is dependent on Ras/ERK1/2 MAPK signaling in osteoblasts.
    Kanno T; Takahashi T; Tsujisawa T; Ariyoshi W; Nishihara T
    J Cell Biochem; 2007 Aug; 101(5):1266-77. PubMed ID: 17265428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JNK signaling plays an important role in the effects of TNF-α and IL-1β on in vitro osteoblastic differentiation of cultured human periosteal-derived cells.
    Hah YS; Kang HG; Cho HY; Shin SH; Kim UK; Park BW; Lee SI; Rho GJ; Kim JR; Byun JH
    Mol Biol Rep; 2013 Aug; 40(8):4869-81. PubMed ID: 23657597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LPS-stimulated inflammation inhibits BMP-9-induced osteoblastic differentiation through crosstalk between BMP/MAPK and Smad signaling.
    Daigang L; Jining Q; Jinlai L; Pengfei W; Chuan S; Liangku H; Ding T; Zhe S; Wei W; Zhong L; Kun Z
    Exp Cell Res; 2016 Feb; 341(1):54-60. PubMed ID: 26794904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effects of Nell-1 and BMP-2 on the osteogenic differentiation of myoblasts.
    Cowan CM; Jiang X; Hsu T; Soo C; Zhang B; Wang JZ; Kuroda S; Wu B; Zhang Z; Zhang X; Ting K
    J Bone Miner Res; 2007 Jun; 22(6):918-30. PubMed ID: 17352654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory effects of fibroblast growth factor-8 and tumor necrosis factor-α on osteoblast marker expression induced by bone morphogenetic protein-2.
    Katsuyama T; Otsuka F; Terasaka T; Inagaki K; Takano-Narazaki M; Matsumoto Y; Sada KE; Makino H
    Peptides; 2015 Nov; 73():88-94. PubMed ID: 26409788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EphB4/ TNFR2/ERK/MAPK signaling pathway comprises a signaling axis to mediate the positive effect of TNF-α on osteogenic differentiation.
    Zhang Y; Yang C; Ge S; Wang L; Zhang J; Yang P
    BMC Mol Cell Biol; 2020 Apr; 21(1):29. PubMed ID: 32299362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term exposure to tumor necrosis factor-alpha enables human osteoblasts to direct adipose tissue-derived mesenchymal stem cells into osteogenic differentiation.
    Lu Z; Wang G; Dunstan CR; Zreiqat H
    Stem Cells Dev; 2012 Sep; 21(13):2420-9. PubMed ID: 22296271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α.
    Takano M; Otsuka F; Matsumoto Y; Inagaki K; Takeda M; Nakamura E; Tsukamoto N; Miyoshi T; Sada KE; Makino H
    Mol Cell Endocrinol; 2012 Jan; 348(1):224-32. PubMed ID: 21888945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells.
    Gallea S; Lallemand F; Atfi A; Rawadi G; Ramez V; Spinella-Jaegle S; Kawai S; Faucheu C; Huet L; Baron R; Roman-Roman S
    Bone; 2001 May; 28(5):491-8. PubMed ID: 11344048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin promotes osteoblastic differentiation through the BMP/ERK/Wnt signaling pathways.
    Park KH; Kang JW; Lee EM; Kim JS; Rhee YH; Kim M; Jeong SJ; Park YG; Kim SH
    J Pineal Res; 2011 Sep; 51(2):187-94. PubMed ID: 21470302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β inhibits osteogenesis by upregulating the expression of ubiquitin ligase SMURF1 via MAPK-ERK signaling.
    Sun X; Xie Z; Ma Y; Pan X; Wang J; Chen Z; Shi P
    J Cell Physiol; 2018 Jan; 233(1):596-606. PubMed ID: 28322449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between extracellular signal-regulated kinase 1/2 and p38 MAP kinase pathways in the control of RUNX2 phosphorylation and transcriptional activity.
    Ge C; Yang Q; Zhao G; Yu H; Kirkwood KL; Franceschi RT
    J Bone Miner Res; 2012 Mar; 27(3):538-51. PubMed ID: 22072425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-1α induces apoptosis and inhibits the osteoblast differentiation of MC3T3-E1 cells through the JNK and p38 MAPK pathways.
    Guo C; Yang XG; Wang F; Ma XY
    Int J Mol Med; 2016 Jul; 38(1):319-27. PubMed ID: 27220839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of adenosine monophosphate-activated protein kinase suppresses bone morphogenetic protein-2-induced mineralization of osteoblasts via Smad-independent mechanisms.
    Takeno A; Kanazawa I; Notsu M; Tanaka KI; Sugimoto T
    Endocr J; 2018 Mar; 65(3):291-298. PubMed ID: 29249772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory effects of bone morphogenetic protein-4 on tumour necrosis factor-α-suppressed Runx2 and osteoprotegerin expression in cementoblasts.
    Wang Y; He H; Cao Z; Fang Y; Du M; Liu Z
    Cell Prolif; 2017 Aug; 50(4):. PubMed ID: 28244247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.